SAN DIEGO, July 31 /PRNewswire-FirstCall/ -- Favrille, Inc. , a biopharmaceutical company developing patient-specific, active immunotherapies for the treatment of cancer, announced today that it will host a conference call and live webcast at 4:30 p.m. Eastern Time on Thursday, August 9, 2007 to discuss the Company’s second quarter 2007 financial results. A press release reporting Favrille’s second quarter 2007 financial results will be issued before the U.S. stock markets open on August 9, 2007.
(Logo: http://www.newscom.com/cgi-bin/prnh/20031013/LAM095LOGO )
A live audio webcast of management’s presentation will be available on the Investor Relations section of the Company’s web site at http://www.favrille.com. Alternatively, callers may participate in the conference call by dialing (800) 322-5044 or (617) 614-4927, passcode 58433289. A telephone replay of the call will also be available for 48 hours. The telephone replay can be accessed by dialing (888) 286-8010 or (617) 801-6888, passcode 35651340.
About Favrille, Inc.
Favrille, Inc. is a biopharmaceutical company focused on the development and commercialization of targeted immunotherapies for the treatment of cancer and other diseases of the immune system. The Company’s lead product candidate, FavId, is based upon unique genetic information extracted from a patient’s tumor. FavId is currently under investigation in a pivotal Phase 3 clinical trial for patients with follicular B-cell NHL and Phase 2 clinical trials in other B-cell NHL indications. The Company is developing additional applications based on its immunotherapy expertise and proprietary cost-effective manufacturing technology, including a second product candidate, FAV-201, for the treatment of cutaneous T-cell lymphoma.
Company Contact: Pete De Spain Director, Investor Relations & Corporate Communications Favrille, Inc. (858) 526-2426 pdespain@favrille.com
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20031013/LAM095LOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comFavrille, Inc.
CONTACT: Pete De Spain, Director, Investor Relations & CorporateCommunications of Favrille, Inc., +1-858-526-2426, pdespain@favrille.com
Web site: http://www.favrille.com/
